{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 0.007845498621463776, "B": 0.02782030962407589, "C": 0.007027658633887768, "D": 0.07275928556919098, "E": 0.030243778601288795}, "ranked_options": [{"letter": "C", "text": "Cyclophosphamide", "avg_nll": 0.007027658633887768}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 0.007845498621463776}, {"letter": "B", "text": "Rituximab", "avg_nll": 0.02782030962407589}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 0.030243778601288795}, {"letter": "D", "text": "Vincristine", "avg_nll": 0.07275928556919098}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 2.943883180618286, "B": 0.8609441518783569, "C": 1.2285231351852417, "D": 1.4910855293273926, "E": 3.4168262481689453}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 0.8609441518783569}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 1.2285231351852417}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 1.4910855293273926}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 2.943883180618286}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 3.4168262481689453}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 2.465123176574707, "B": 3.586625337600708, "C": Infinity, "D": 2.75919246673584, "E": 0.3735330402851105}, "ranked_options": [{"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 0.3735330402851105}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 2.465123176574707}, {"letter": "D", "text": "Brain abscess", "avg_nll": 2.75919246673584}, {"letter": "B", "text": "Dementia", "avg_nll": 3.586625337600708}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 1.3208175897598267, "B": 1.1649119853973389, "C": 1.8339020013809204, "D": 2.6183321475982666, "E": 2.734224796295166}, "ranked_options": [{"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 1.1649119853973389}, {"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 1.3208175897598267}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 1.8339020013809204}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 2.6183321475982666}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 2.734224796295166}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 4.167361259460449, "B": 4.531511306762695, "C": 3.019315719604492, "D": 0.8107002973556519, "E": 3.277622938156128}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 0.8107002973556519}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 3.019315719604492}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 3.277622938156128}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 4.167361259460449}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 4.531511306762695}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 1.9489822387695312, "B": 1.9989821910858154, "C": 0.2076902836561203, "D": 1.6868568658828735, "E": 1.9160236120224}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 0.2076902836561203}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 1.6868568658828735}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 1.9160236120224}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 1.9489822387695312}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 1.9989821910858154}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 0.6936383843421936, "B": 1.559131145477295, "C": 1.2118098735809326, "D": 5.138942718505859, "E": 1.7685141563415527}, "ranked_options": [{"letter": "A", "text": "Omnipaque 320", "avg_nll": 0.6936383843421936}, {"letter": "C", "text": "Optiray 320", "avg_nll": 1.2118098735809326}, {"letter": "B", "text": "Imeron 400", "avg_nll": 1.559131145477295}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 1.7685141563415527}, {"letter": "D", "text": "Gadovist", "avg_nll": 5.138942718505859}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 2.760091543197632, "B": 2.2463626861572266, "C": 2.7344560623168945, "D": 3.6666040420532227, "E": 3.353886842727661}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 2.2463626861572266}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 2.7344560623168945}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 2.760091543197632}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 3.353886842727661}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 3.6666040420532227}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 0.8656049966812134, "B": 2.6655468940734863, "C": 1.1643842458724976, "D": 2.0414066314697266, "E": 3.0845210552215576}, "ranked_options": [{"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 0.8656049966812134}, {"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 1.1643842458724976}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 2.0414066314697266}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 2.6655468940734863}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 3.0845210552215576}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 2.4577925205230713, "B": 2.102097749710083, "C": 3.051492214202881, "D": 1.7975915670394897, "E": 2.659960985183716}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 1.7975915670394897}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 2.102097749710083}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 2.4577925205230713}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 2.659960985183716}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 3.051492214202881}], "correct_answer_letter": "B", "error": null, "method": "local"}
